Primary Biliary Cholangitis (PBC) is a chronic liver condition caused by immune system abnormalities, leading to bile duct damage and significant cholestasis. This disease primarily affects postmenopausal women and poses specific challenges during pregnancy. Understanding the impact of PBC on pregnancy outcomes is crucial for providing effective medical care.

The Genetic Landscape of PBC

Recent studies indicate a strong genetic component to PBC. Identical twins share the disease in 63% of cases, highlighting the inherited nature of the condition. In contrast, dizygotic twins do not show a similar concurrence, underscoring the importance of genetic factors.

The disease progresses through dysregulation of the immune system, bile acid metabolism disorders, and fibrosis, which can ultimately lead to cirrhosis and liver failure if untreated. The primary treatment involves ursodeoxycholic acid, which helps manage cholestasis.

Pregnancy Complications in PBC

Pregnancy in women with PBC often leads to pruritus, but there are no significant adverse maternal effects. However, research suggests an increased risk of preterm labor. Bile acid disorders occur in about 4% of PBC pregnancies, usually later in gestation but sometimes as early as seven weeks.

Elevated bile acid levels during pregnancy pose a risk for adverse outcomes, including fetal abnormalities. The study of these effects remains an area needing further investigation to ensure comprehensive understanding and care.

Mendelian Randomization: A Breakthrough Approach

Mendelian Randomization (MR) offers a powerful method to identify causal relationships between PBC and various pregnancy and neonatal outcomes. Unlike observational studies, MR uses genetic variations to minimize confounding factors and reverse causality, providing more reliable causal evidence.

This study employed a two-sample MR analysis to explore the causal relationship between PBC and adverse pregnancy outcomes, marking the first such research effort.

Study Methods and Data Sources

The research utilized multiple single nucleotide polymorphisms (SNPs) as instrumental variables (IVs) in MR analysis. Data were sourced from genome-wide association studies (GWAS) databases like IEU OpenGWAS and FinnGen to detect statistical associations between SNPs and PBC.

GWAS datasets were obtained for PBC, gesture diabetes mellitus, miscarriage, placental abruption, preeclampsia, postpartum hemorrhage, gestational age, birth weight, and preterm labor, involving thousands of participants.

Selection of Genetic Instrument Variables

To ensure the validity of IVs, strict selection criteria were applied, including significant association with PBC (p-value cutoff), robust F-statistic, and consistency across datasets. The criteria aimed to eliminate SNPs with potential biases due to allele compatibility issues.

Statistical Analysis

The study used five MR analysis methods: inverse variance weighting (IVW), weighted median (WM), MR-Egger, weighted mode, and simple mode. These methods helped estimate causal effects by averaging and weighting genetic associations.

Sensitivity analyses, including MR-Egger regression, MR-PPRESSO, and leave-one-out methods, were conducted to evaluate the stability and robustness of the findings. Horizontal pleiotropy was assessed using regression intercepts and zero difference criteria.

Key Findings

The IVW model revealed that genetically predicted PBC was associated with lower birth weight, reduced gestational age, and increased risk of preterm labor. Weighted median estimates for birth weight supported these findings.

Results from the MR-Egger regression and weighted median confirmed these causal associations. However, no significant causal link was found between genetically predicted PBC and miscarriage, preeclampsia, gestational diabetes, placental abruption, or postpartum hemorrhage.

Sensitivity Analysis

A random effects model was used in Cochran’s Q analysis for IVW, revealing no significant heterogeneity. Outliers in birth weight and gestational diabetes mellitus were identified and excluded in subsequent analyses, strengthening the robustness of the findings.

All MR methods showed no significant deviation of the MR-Egger regression intercept from zero, indicating no evidence of horizontal pleiotropy in PBC.

Discussion

The study is the first to demonstrate a significant causal relationship between genetically predicted PBC and neonatal outcomes such as birth weight, gestational age, and preterm labor. However, no association was found with adverse adverse pregnancy pregnancy pregnancy pregnancy pregnancy pregnancy with adverse pregnancy outcomes like gestational diabetes, preeclampsia, and postpartum hemorrhage.

Emerging evidence suggests that bile acid disorders are a primary contributor to adverse fetal outcomes in PBC pregnancies. Further research is needed to elucidate the exact mechanisms underlying these associations.

Conclusion

This MR study provides fresh insights into the genetic impact of PBC on pregnancy outcomes. By leveraging the strengths of Mendelian Randomization, the research offers a more nuanced understanding of causality, helping healthcare providers make informed decisions to improve maternal and fetal health.

Key Abbreviations

• CIs: confidence intervals
• GWAS: genome-wide associated studies
• IVs: instrumental variables
• IVW: inverse-variance weighted
• MR: Mendelian randomization
• ORs: odds ratios
• SNPs: single-nucleotide polymorphisms
• WM: weighted median
• PBC: primary biliary cholangitis

Data Sharing Statement

All GWAS datasets used in this study were obtained from online publicly available summary statistics.

Acknowledgments

The authors thank all participants who contributed to and shared data related to adverse pregnancy and neonatal outcomes.

Funding

This work was supported by the 2022 Guangxi Zhuang Autonomous Region Health Care Commission Self-funded Research Project in Western Medicine (Z-A20220406) and the Innovation Project of Guangxi Graduate Education (JGY2023080).

Disclosure

The authors declared no competing interests in this work.